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Abstract Cardiac lipid accumulation is associated with
decreased cardiac function and energy status (PCr/ATP). It
has been suggested that elevated plasma fatty acid (FA)
concentrations are responsible for the cardiac lipid accu-
mulation. Therefore, the aim of the present study was to
investigate if elevating plasma FA concentrations by
exercise results in an increased cardiac lipid content, and
if this inﬂuences cardiac function and energy status. Eleven
male subjects (age 25.4 ± 1.1 years, BMI 23.6 ± 0.8 kg/m
2)
performed a 2-h cycling protocol, once while staying fasted
and once while ingesting glucose, to create a state of high
versus low plasma FA concentrations, respectively. Car-
diac lipid content was measured by proton magnetic reso-
nance spectroscopy (
1H-MRS) at baseline, directly after
exercise and again 4 h post-exercise, together with systolic
function (by multi-slice cine-MRI) and cardiac energy
status (by
31P-MRS). Plasma FA concentrations were
increased threefold during exercise and ninefold during
recovery in the fasted state compared with the glucose-fed
state (p\0.01). Cardiac lipid content was elevated at the
end of the fasted test day (from 0.26 ± 0.04 to 0.44 ±
0.04%, p = 0.003), while it did not change with glucose
supplementation (from 0.32 ± 0.03 to 0.26 ± 0.05%,
p = 0.272). Furthermore, PCr/ATP was decreased by 32%
in the high plasma FA state compared with the low FA
state (n = 6, p = 0.014). However, in the high FA state,
the ejection fraction 4 h post-exercise was higher com-
pared with the low FA state (63 ± 2 vs. 59 ± 2%, p =
0.018). Elevated plasma FA concentrations, induced by
exercise in the fasted state, lead to increased cardiac lipid
content, but do not acutely hamper systolic function.
Although the lower cardiac energy status is in line with a
lipotoxic action of cardiac lipid content, a causal relation-
ship cannot be proven.
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Introduction
Hospitalization for congestive heart failure is increasing
worldwide [20]. This increase is associated with the
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DOI 10.1007/s00395-010-0144-xincreasing prevalence of obesity [6, 10], which is an
independent risk factor for the development of heart failure
[11]. Obesity is associated with excessive storage of lipids
(triglycerides) not only in adipose tissue but also in skeletal
muscle, the liver and the heart. It has been suggested that
lipid accumulation in cardiac tissue may have lipotoxic
effects, thereby hampering cardiac function and predis-
posing to cardiomyopathy and heart failure. Cardiac lipo-
toxicity is well documented in both obese [31, 36] and lean
animal models with exaggerated storage of fat in cardiac
muscle induced by targeted over expression of genes
involved in lipid delivery and synthesis in the myocardium
[1–3, 17, 35], but direct evidence for cardiac lipotoxicity in
humans is scarce. However, proton magnetic resonance
spectroscopy (
1H-MRS) has recently been proven reliable
for non-invasive in vivo investigation of cardiac tissue and
enables human interventional studies [29, 32]. Such studies
have indicated that cardiac lipid accumulation is elevated
in conditions of increased circulating fatty acid (FA) con-
centrations, such as obesity [5], a very low calorie diet [33]
and fasting [18], and circulating FA concentrations were
found to correlate with cardiac lipid content [5]. These data
suggest that the cardiac uptake of FA is not tightly matched
to oxidational needs but rather follows circulating FA
concentrations. In addition, it has been shown that high
plasma FA concentrations correlate negatively with the
energy status of the heart [21], and the latter has a strong
prognostic value in heart failure patients and might be an
early marker of disturbed cardiac metabolism [16].
In that respect, it is interesting to examine the effect of
acute exercise on cardiac lipid content and function. Acute
exercise—when performed in the fasting state—is associ-
ated with a threefold elevation of plasma FA concentra-
tions [22]. However, when acute exercise is performed
while providing carbohydrate beverages, the increase in FA
can be completely blunted. It could be hypothesized that
cardiac lipid content will increase during exercise per-
formed in the fasting state, due to elevated plasma FA
concentrations. On the other hand, lipid content in skeletal
muscle can be lowered by prolonged acute exercise [24]
even despite high circulatory FA concentrations, due to
increased fat oxidation to fuel physical activity. We have
recently shown that prolonged endurance training
decreased cardiac lipid content in parallel with improve-
ments in cardiac function [23]. Thus, it can also be
hypothesized that cardiac fat content will decrease during
exercise due to an increased oxidation of FA needed to
meet the increased cardiac work. Therefore, comparing the
effect of acute exercise with high versus low circulating FA
concentrations will allow us to test the hypothesis that
physiologically induced elevation of plasma FA concen-
trations lead to an unrestricted uptake of FA in cardiac
tissue, subsequent accumulation of intracardiac fat, and an
ultimate reduction in cardiac function and cardiac energy
status. To this end, we employed
1H-MRS to determine
cardiac lipid content before and after exercise as well as
4 h post-exercise. MRI and
31P-MRS were employed 4 h
post-exercise to determine cardiac function and cardiac
energy status, respectively.
Materials and methods
Subjects
Eleven healthy lean, untrained young men participated in
this study. Subjects’ characteristics are shown in Table 1.
None of the subjects participated in competitive sports, and
subjects with unstable weight ([3 kg change in preceding
6 months) were excluded from the study. The institutional
medical ethical committee approved the study, and written
informed consent was obtained from all participants.
Study protocol
Before the start of the study, body composition and
maximal aerobic capacity was determined in all subjects.
The experimental trial comprised two separate test days.
Subjects refrained from physical activity 2 days prior to the
test days. Furthermore, subjects were instructed to consume
a standardized meal the evening prior to the test days and
stay fasted from 10 pm onwards. On the test days, subjects
came to the laboratory at 7:00 am after an overnight fast.
Cardiac lipid content was investigated by
1H-MRS. After
this, a Teﬂon canula was inserted into an antecubital vein
for sampling of blood. Immediately after taking the ﬁrst
blood sample, subjects ingested 1.4 g/kg bodyweight of
glucose (dissolved in water to a 20% solution and ﬂavored
with 1 ml lemon juice) or the same amount of water on the
test day in fasted state. Next, subjects were guided to
another lab where they started exercising at 50% of their
maximal power output (t = 0 min). The exercise period
lasted for 2 h, and during exercise blood samples were
taken, and substrate oxidation was measured by indirect
calorimetry for 15 min (Omnical, Maastricht, The
Table 1 Subjects’ characteristics
Subjects’ characteristics Mean ± SE
Age (years) 25.4 ± 1.1
Height (m) 1.79 ± 0.02
Weight (kg) 75.8 ± 3.5
BMI (kg/m
2) 23.6 ± 0.8
Fat (%) 18.3 ± 2.0
VO2max/kg (ml 9 min
-1 9 kg
-1) 45.9 ± 2.2
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123Netherlands) every 30 min (at t = 30, 60, 90 and 120 min).
Immediately after cessation of the 2 h of exercise, a second
1H-MRS measurement was performed. Subsequently, sub-
jects bed-rested for 3 h, and a third
1H-MRS scan together
with additional measurements of ejection fraction (by CINE-
MRI) and cardiac energy status (by
31P-MRS) were started
4 h after exercise. During this post-exercise period, blood
samples were taken, and substrate oxidation was measured
for 15 min every hour (at t = 180, 240, 300 and 360 min).
The experimental design is depicted in Fig. 1.
The entire protocol was performed twice: once with the
ingestion of glucose (0.35 g/kg bodyweight at t =- 15,
30, 60, 90, 180, 240, 300 and 360) after the initial bolus of
1.4 g/kg of bodyweight and once in the fasted state with
ingestion of equal amounts of water. Both test days were
separated by at least 1 week and were performed in random
order. On a separate day, a reference measurement of
cardiac function without prior exercise was performed in
the morning after an overnight fast.
Maximal oxygen uptake (whole body oxidative
capacity)
A routine incremental cycling test was used to determine
maximal aerobic capacity as described previously [8].
Brieﬂy, after a warming-up period of 5 min, the intensity
was increased every 2.5 min until exhaustion. Oxygen
consumption was measured continuously throughout the
test using indirect calorimetry (Omnical, Maastricht, The
Netherlands) to determine VO2max.
Hydrostatic weighing
Hydrostatic weighing with simultaneous measurement of
lung volume was used to determine body composition in the
morning in the fasted state. The equation of Siri [28]w a s
used to calculate fat percentage, fat mass and fat-free mass.
Blood sample analysis
Blood samples were collected in EDTA-containing tubes
and immediately centrifuged at high speed and frozen
in liquid nitrogen and thereafter stored at -80C until
assayed. Plasma fatty acids, triglycerides and glucose were
measured with enzymatic assays automated on a Cobas
Fara/Mira (FA: Wako Nefa C test kit, Wako Chemicals,
Neuss, Germany) (glucose: hexokinase method, Roche,
Basel, Switzerland) (triglycerides: ABX Pentra CP
reagents, Horiba ABX Diagnostics, Montpellier, France)
(glycerol: Enzytec
TM glycerol kit, R-Biopharm, Germany).
MRI
Cardiac CINE-MRI examinations were performed on a
whole body MRI-scanner (Intera, 1.5 T, Philips Healthcare,
Best, The Netherlands) as reported previously [32]. At the
end of the test day, slices covering the whole left ventricle
were acquired in 24 heart phases to determine parameters
of systolic function. During the other measurements, only
four slices were acquired, which was sufﬁcient to guide
spectroscopy.
Image processing
All images were analyzed quantitatively, and ten images
were examined for inter-observer reliability using dedi-
cated software (CAAS, Pie Medical Imaging, Maastricht,
The Netherlands) to determine end diastolic and end sys-
tolic volumes, left ventricular stroke volume, ejection
fraction, cardiac output and cardiac index.
1H-MRS
Cardiac lipid content was determined in vivo by
1H-MRS
as reported previously [23]. Respiratory gating and track-
ing was performed with a pencil beam navigator placed on
the diaphragm [32]. Chemical shift selective (CHESS)
water suppression was performed to acquire spectra of the
lipid metabolites using a series of 32 spectra (n = 2 each),
resulting in a total of 64 acquisitions. To acquire a refer-
ence spectrum of the unsuppressed water peak in the same
volume of interest, the acquisition was repeated, with the
CHESS pulse off resonance, using a series of 12 spectra
(n = 2 each), resulting in a total of 24 acquisitions. From
11 subjects, 2 had to be excluded from the cardiac lipid
content analysis due to poor quality of spectra.
Fig. 1 Experimental design of
the study. All subjects
performed the protocol two
times, one time in the fasted
state consuming water and one
time with glucose
supplementation. MRS cardiac
magnetic resonance
spectroscopy
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1231H-MRS spectral post-processing
Post-processing of the spectra was performed with the
jMRUI software [7]. All
1H MR spectroscopic data were
ﬁtted in the time domain. Manual phase correction was
performed, and subsequently, all spectra with water sup-
pression and without were averaged, resulting in one water-
suppressed lipid spectrum originating from 128 averages
and a non-suppressed spectrum from 24 averages for
quantiﬁcation of the water resonance. Myocardial lipid
peaks were ﬁtted by using the Advanced magnetic reso-
nance (AMARES) ﬁtting algorithm [34] within the jMRUI
software [15] as reported earlier [32]. Cardiac lipid content
is given as the percentage of the CH2 peak compared to the
water resonance, uncorrected for T1 and T2 relaxation.
31P-MRS
Single voxel cardiac
31P-MRS spectra were obtained from
the left ventricle with subjects in the supine position as
reported previously [9]. A 10 cm coil was ﬁxed on the
chest, at the level of the myocardium. Manual tuning
and matching of the
31P-surface coil was performed to
adjust for different coil loadings. ECG-triggered ISIS was
used for localization to the left ventricle (TR = 3.6 s,
n = 192). Spectroscopy and shimming volumes were pla-
nned on the transverse and sagittal scout images to
include the entire left ventricle, while avoiding chest wall
muscle and diaphragm muscle. A rest slab was placed
over the chest muscle to minimize contamination from
skeletal muscle.
31P-MRS spectral post-processing
31P-MRS was quantiﬁed with the dedicated software
jMRUI. Signals were quantiﬁed in the time domain. Six
Gaussian peaks were ﬁtted using prior knowledge deﬁning
chemical shift. The ATP level in the
31P-MRS was cor-
rected for the ATP contribution from blood and T1 cor-
rected [4].
Statistics
Data are presented as mean ± SE. A two-way ANOVA for
repeated measures was performed to analyze data over time
for cardiac lipid content, substrate oxidation and plasma
values of FA, glucose, triglycerides and glycerol. Statistical
differences in ejection fraction and PCr/ATP between the
two conditions were determined by a paired Student t test.
All statistics were performed using SPSS 16.0 for Mac, and
p\0.05 was considered statistically signiﬁcant.
Results
Energy expenditure and substrate oxidation
No signiﬁcant differences in energy expenditure between
the glucose-fed and the fasted state were found neither
during exercise nor during post-exercise (see Table 2).
During exercise, there was a signiﬁcant time (p\0.01)
and treatment (p\0.01) effect for respiratory quotient
(RQ), without a time 9 treatment interaction (p = 0.39)
effect. RQ was signiﬁcantly higher at all time points in the
glucose-fed state compared with the fasted state (p\0.01)
(see Fig. 2a), reﬂecting higher carbohydrate oxidation in
glucose-fed state, and RQ decreased between t = 30 and
t = 90 min (p\0.05) in both conditions. In the post-
exercise period, a signiﬁcant treatment effect (p\0.01)
was revealed, but no time (p = 0.88) or time 9 treatment
(p = 0.10) effects were present. Also under resting con-
ditions post-exercise, RQ was signiﬁcantly higher in the
Table 2 Energy expenditure and fat and carbohydrate oxidation during and after exercise in glucose-supplemented and fasted states
Treatment Time (min) Glucose Fasted
EE (kJ/min) Fat oxidation
(mg/min)
CHO oxidation
(mg/min)
EE (kJ/min) Fat oxidation
(mg/min)
CHO oxidation
(mg/min)
Exercise 30 41.9 ± 1.5 313 ± 31* 1,871 ± 80* 41.7 ± 1.6 476 ± 83 1,451 ± 151
60 41.9 ± 1.2 398 ± 27
# 1,659 ± 73
# 42.0 ± 1.3 530 ± 31 1,336 ± 88
90 42.3 ± 1.4 469 ± 27
# 1,503 ± 67
# 42.3 ± 1.5 635 ± 16 1,092 ± 85
120 43.8 ± 1.9 467 ± 3
# 1,606 ± 137
# 42.5 ± 1.8 665 ± 22 1,026 ± 124
Post-exercise 240 5.3 ± 0.2 45 ± 8
# 226 ± 19
# 5.5 ± 0.2 95 ± 7 109 ± 11
300 5.4 ± 0.2 30 ± 5
# 267 ± 17
# 5.5 ± 0.2 103 ± 59 3 ± 11
360 5.4 ± 0.2 30 ± 6
# 269 ± 18
# 5.6 ± 0.2 104 ± 69 2 ± 11
Data are means ± SEM
EE energy expenditure, CHO carbohydrate
* p\0.05 and
#p\0.01 compared with fasted treatment
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123glucose-fed state compared with the fasted state at all time
points (\0.01).
During exercise, there was a signiﬁcant time (p\0.01)
and treatment (p\0.01) effect for both carbohydrate and
fat oxidation, without a time 9 treatment interaction
(p = 0.38 and 0.27, respectively) effect. As depicted in
Table 2, carbohydrate oxidation was signiﬁcantly higher at
all time points in the glucose-fed state compared with the
fasted state (p\0.01), whereas fat oxidation was signiﬁ-
cantly higher at all time points in the fasted state compared
with the glucose-fed state (p\0.05). Both carbohydrate
and fat oxidation increased between t = 30 and t = 90
(p\0.01). In the post-exercise period, the carbohydrate
oxidation was signiﬁcantly higher in the glucose-fed state
compared with the fasted state at all time points (p\0.01),
whereas the fat oxidation was signiﬁcantly higher in the
fasted state compared with the glucose-fed state at all time
points (p\0.01). There was no time or time 9 treatment
interaction effect for neither carbohydrate nor fat oxidation
in the post-exercise period (p[0.05).
Blood plasma concentrations
During exercise, there was a signiﬁcant time (p\0.01),
treatment (p\0.01) and time 9 treatment interaction
(p\0.01) effect for plasma FA concentrations. Except for
baseline (t = 0), plasma FA concentrations were higher at
all time points during exercise in the fasted state (p\0.01)
compared with the glucose-fed state (Fig. 2b). Plasma FA
concentrations increased with time during exercise
(p\0.01), with this increase being more pronounced in
the fasted state compared to the glucose-fed state. In the
post-exercise period, plasma FA concentrations were
higher at all time points in the fasted state compared with
the glucose-fed state (p\0.001), but there was no time or
time 9 treatment interaction effect.
During exercise, there was a signiﬁcant time
(p\0.05), treatment (p\0.01) and time 9 treatment
interaction (p\0.01) effect for plasma glucose concen-
trations. In the fasted state, plasma glucose concentrations
decreased during exercise (Fig. 2c), whereas an increase
Fig. 2 a Respiratory quotient during and after 2 h of cycling at 50%
of maximal power output (Wmax) and plasma concentrations of
b (free) fatty acids (FA), c glucose and d triglyceride (TG), with
(open square) and without (ﬁlled square) glucose supplementation.
a–d *p\0.01 compared with glucose-supplemented condition.
a–d
p\0.05 changes over time compared with baseline (t =- 60).
Data are mean ± SE
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123was observed in the glucose-fed state. As a result, plasma
glucose levels were higher in the glucose-fed state com-
pared with the fasted state from time point t = 60 min
onwards (p\0.05). In the post-exercise period, plasma
glucose concentrations were higher at all time points in
the glucose-fed state compared with the fasted state
(p\0.01), and there was a time 9 treatment interaction
(p = 0.046) effect, but there was no time (p = 0.085)
effect.
During exercise, there was no signiﬁcant time
(p = 0.16), treatment (p = 0.22) or time 9 treatment
interaction (p = 0.87) effect for plasma triglyceride con-
centrations, whereas there was a tendency to higher plasma
triglyceride concentrations post-exercise in the glucose-fed
state compared with the fasted state (p = 0.069; Fig. 2d).
There was no time (p = 0.95) or time 9 treatment inter-
action (p = 0.99) effect for plasma triglyceride concen-
trations post-exercise. Considering all time points of the
test day, there is an overall time effect with triglyceride
concentrations decreasing over time, being signiﬁcantly
different from baseline levels in the fasted condition from
t = 120 min onwards (p[0.05).
There was a signiﬁcant time (p\0.01), treatment
(p\0.01) and time 9 treatment interaction (p\0.01)
effect for glycerol during exercise. Glycerol concentrations
were higher in the fasted state, and increased during
exercise, with a more pronounced increase in the fasted
state (from 99 ± 14 to 620 ± 31 lmol/l in the fasted state
vs. 91 ± 9 to 219 ± 27 lmol/l in the glucose-fed state).
Post-exercise glycerol was signiﬁcantly higher in the fasted
state compared with the glucose-fed state (135 ± 9 vs.
46 ± 3 lmol/l at t = 360) (p\0.01), but there was no
time (0.11) or time 9 treatment interaction (p = 0.22)
effect.
Cardiac lipid content
There was a signiﬁcant treatment (p = 0.029) and
time 9 treatment interaction (p = 0.009) effect for car-
diac lipid content, but no time (p = 0.242) effect. As
depicted in Fig. 3, overall cardiac lipid content was
higher at the end of the test day in the fasted state
compared with the glucose-fed state, and cardiac lipid
content increased after recovery from exercise in the
fasted state (p = 0.003), whereas it did not change when
glucose supplementation was given (p = 0.272). At
baseline, there were no differences in cardiac lipid con-
tent between the two conditions (p = 0.239). Cardiac
lipid content was also not different between the two
conditions directly after exercise (p = 0.119). However,
4 h post-exercise cardiac lipid content was elevated by
41% in the fasted state compared with the glucose-fed
state (p = 0.008).
Cardiac energy status and function
In a subgroup of six subjects, PCr/ATP was determined 4 h
post-exercise. PCr/ATP was 32% lower in the fasted state
compared with the glucose-fed state (p = 0.014; Fig. 4).
Ejection fraction (p = 0.038; Fig. 5), stroke volume
(115 ± 6 vs. 107 ± 4 ml, p = 0.044), cardiac output
(7.2 ± 0.5 vs. 6.0 ± 0.2 l/min, p = 0.016) and cardiac
index (3.9 ± 0.3 vs. 3.3 ± 0.2 l/min/m
2, p = 0.016) were
all signiﬁcantly higher at 4 h of recovery in the fasted state
compared with the glucose-fed state. At 4 h of recovery,
end diastolic (182 ± 8 ml in the fasted state vs. 180 ±
8 ml in the glucose-fed state, p = 0.626) and end systolic
(68 ± 4 ml in the fasted state vs. 73 ± 5 ml in the glu-
cose-fed state, p = 0.179) volumes were not signiﬁcantly
different between the fasted and glucose-fed states. A
tendency to a higher heart rate during these measurements
in the fasted state was found, compared with the glucose-
fed state; however, it did not reach statistical signiﬁcance
(63 ± 3 vs. 58 ± 3 bpm, p = 0.097). Inter-observer vari-
ability of ejection fraction analysis was good with a coef-
ﬁcient of variation of 3.6 ± 0.9%.
To compare the values for cardiac function at 4 h of
recovery to baseline reference values without prior exercise,
we measured, in the same subjects, cardiac function after an
overnight fast, on a separate day. 4 h-recovery values for
ejection fraction (p = 0.026; Fig. 5), cardiac output
(7.2 ± 0.5 vs. 5.8 ± 0.3 ml, n = 9, p = 0.015) and cardiac
index(3.7 ± 0.3vs.3.0 ± 0.2 l/min/m
2,n = 9,p = 0.007)
wereallsigniﬁcantlyhigherinthefastedstatecomparedwith
the reference measurement, whereas the glucose-fed state
did not differ from the reference measurement (p[0.05).
There was no difference in stroke volume between the ref-
erence measurement and the fasted (p = 0.933) or the glu-
cose-fed (p = 0.241) states. Heart rate was signiﬁcantly
lowerduringthereferencemeasurementcomparedwithboth
Fig. 3 Cardiac lipid content at baseline, directly post-exercise and
4 h post-exercise. Cardiac lipid content is expressed as the relative
intensity of the CH2 peak, compared to the unsuppressed water
resonance. n = 9, *p\0.01. Data are mean ± SE
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123the measurement in the fasted (52 ± 4 vs. 62 ± 4 bpm,
n = 9, p = 0.001) and glucose-fed state (52 ± 4 bpm
58 ± 3 bpm, n = 9, p = 0.013) at 4 h of recovery.
Discussion
The primary ﬁnding of the present study is that cardiac lipid
content increases upon exercise-induced—i.e. physiologi-
cal—elevation of plasma FA concentrations in healthy lean
young men. Furthermore, we revealed that this increase in
cardiac lipid content is paralleled by a lower cardiac energy
status (lower PCr/ATP), but not by a lowered cardiac
function. These results indicate that cardiac muscle is rather
unrestricted in its uptake of circulating FA and that the
validity of PCr/ATP ratio as a relevant marker of cardiac
function can be debated under some circumstances.
There is an increasing prevalence of obesity worldwide,
and obesity is well known to be an independent risk factor
for the development of heart failure. Obesity is associated
with excessive storage of lipids (triglycerides) not only in
adipose tissue, but also in non-adipose tissues, such as the
heart. We show here for the ﬁrst time that cardiac lipid
content is increased upon exercise-induced elevation of
plasma FA concentrations in healthy lean young men, and
that blunting of the exercise-induced increase in plasma FA
concentrations completely prevents the increase in cardiac
lipid content. This suggests that in healthy lean young men
plasma FA concentration is an important determinant of
cardiac lipid content, which in turn suggests that in this
population uptake of FA in the heart largely depends on FA
availability. This is in agreement with previous studies
pointing at the importance of high FA concentrations as
determinants of cardiac lipid content [5]. Increased cardiac
lipid content is shown to be associated with obesity and
diabetes [5, 26, 30, 32], conditions in which it is well
known that plasma FA concentrations are high. Further-
more, fasting for more than 48 h [18] or a very low calorie
diet for more than 3 days [33], which both are character-
ized by elevated plasma FA concentrations, also resulted in
increased cardiac lipid content. Although our results may
suggest that elevated plasma FA concentrations may also
underlie cardiac lipid accumulation and cardiac dysfunc-
tion in obesity and diabetes, it is important to note that
major differences exist between obesity, insulin resistance
and fasting. Thus, although both conditions are character-
ized by elevated plasma FA concentrations, plasma leptin
and insulin levels are elevated in obesity, but markedly
reduced upon fasting. It has recently been shown that under
conditions of systemic insulin resistance the heart remains
insulin sensitive [25]; therefore, chronic stimulation of
multiple signaling processes in the myocardium by leptin
and insulin may result in cardiac pathology.
Interestingly, our ﬁndings that elevated plasma FA lead
to cardiac lipid accumulation are to some extent in accor-
dance with observations in skeletal muscle. Thus, we have
previously shown that during exercise, when peripheral
lipolysis is stimulated to increase plasma FA availability
for subsequent oxidation, a net accumulation of intra-
myocellular lipids occurred in non-exercising muscles
of the upper arm, indicating that high circulatory FA
concentrations also lead to unrestricted uptake of FA in
skeletal muscle [24]. However, intramyocellular lipid
content was reduced in the exercising muscles of the leg,
suggesting that in this active muscle FA delivery was
customized to FA oxidation. In that respect, it is surprising
that in cardiac muscle, which heavily relies on FA for
oxidation during exercise, the elevation of plasma FA lead
to an increase rather than a decrease in cardiac lipid con-
tent. This suggests that the uptake of FA in cardiac muscle
is less well-tuned to the oxidative needs compared to
skeletal muscle and that even under conditions of increased
cardiac work, FA entering the heart are shuttled towards
storage rather than to oxidation.
In parallel to the increased cardiac lipid content, we also
observed a lower cardiac energy status (lower PCr/ATP).
Fig. 4 PCr/ATP ratio 4 h post-exercise, n = 6, *p = 0.014. Data are
depicted both as individual and mean ± SE
Fig. 5 Left ventricular ejection fraction 4 h post-exercise, with
(white bar) and without (black bar) glucose ingestion, compared
with a reference (gray bar) measurement. *p\0.05. Data are
mean ± SE
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123Cardiac energy status has a strong prognostic value in heart
failure patients, and it has been suggested to be an early
marker of disturbed cardiac metabolism [16]. In line
with this, Scheuermann-Freestone et al. [21] found that the
PCr/ATP ratios correlate negatively with plasma FA con-
centrations. Furthermore, a decreased PCr/ATP ratio has
been found to be associated with diastolic dysfunction and
diabetes [19]. As an explanation for this ﬁnding, it has been
suggested that plasma FA increase the expression of
mitochondrial uncoupling proteins in the heart, and these
proteins can reduce the efﬁciency with which mitochondria
can produce ATP, thereby resulting in altered PCr/ATP
ratios [12]. Some care should be taken when interpreting
PCr/ATP ratios as energy status, as the assumption that a
decreased PCr/ATP ratio is reﬂecting a decreased PCr/Cr
ratio which can theoretically be biased by a decrease in
total creatine concentration. In that context, other studies
have shown that indeed creatine concentration in the failing
heart is decreased [13, 14, 27]. In the current study, we
cannot exclude that creatine depletion contributes to the
lower PCr/ATP ratio found in the fasted condition.
However, even though an increased cardiac lipid con-
tent was associated with a lower cardiac energy status in
the present study, the systolic cardiac function was not
negatively affected. The systolic cardiac function was
determined by multi-slice CINE-MRI, which is the gold
standard for measuring systolic cardiac function. Together
with myocardial spectroscopy, this permits examinations
of associations between myocardial triglyceride concen-
trations and cardiac function. Surprisingly, cardiac func-
tion was higher in the condition with high plasma FA
concentrations and elevated cardiac lipid content com-
pared with the glucose-fed state. Moreover, cardiac
function in the fasted state was in fact elevated when
compared with the reference condition. Increased con-
centrations of adrenaline and noradrenaline may be
underlying the stronger contraction in that case. Alterna-
tively, changes in peripheral resistance may occur with
the current protocol, which may affect ejection fraction.
Although the exact mechanism explaining the increased
cardiac function in the high plasma FFA condition
remains speculative, we can conclude that, if anything,
the elevated plasma FA concentrations and concomitant
cardiac lipid content did not negatively impact cardiac
function. This shows that at least in this population PCr/
ATP ratio is not a good marker of cardiac function under
acute conditions of elevated FA.
In summary, in this study, we revealed that elevated
plasma FA concentrations, induced by prolonged exercise
in the fasted state, increased storage of triglycerides in
cardiac tissue, but did not acutely hamper systolic function.
Although the lower cardiac energy status is in line with a
lipotoxic action of cardiac lipids, a causal relationship
cannot be proven, and it cannot be excluded that acute
prolonged exercise inﬂuences cardiac energy status and
lipid content independently.
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